Calcium Channels in the Heart

Cardiac Electrophysiology: From Cell to Bedside: Sixth Edition

Volumn , Issue , 2014, Pages 13-22

  Rose, Robert A ^a   Backx, Peter H ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84940217712     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4557-2856-5.00002-9     Document Type: Chapter

References (136)

1. Bers DM Cardiac excitation-contraction coupling. Nature 2002, 415:198-205.
2. Best JM, Kamp TJ Different subcellular populations of L-type Ca2+ channels exhibit unique regulation and functional roles in cardiomyocytes. J Mol Cell Cardiol 2012, 52:376-387.
3. Benitah JP, Alvarez JL, Gomez AM L-type Ca(2+) current in ventricular cardiomyocytes. J Mol Cell Cardiol 2010, 48:26-36.
4. Pitt GS, Dun W, Boyden PA Remodeled cardiac calcium channels. J Mol Cell Cardiol 2006, 41:373-388.
5. Catterall WA Voltage-gated calcium channels. Cold Spring Harb Perspect Biol 2011, 3:a003947.
6. Catterall WA Structure and regulation of voltage-gated Ca2+ channels. Annu Rev Cell Dev Biol 2000, 16:521-555.
7. Schram G, Pourrier M, Melnyk P, et al. Differential distribution of cardiac ion channel expression as a basis for regional specialization in electrical function. Circ Res 2002, 90:939-950.
8. Bock G, Gebhart M, Scharinger A, et al. Functional properties of a newly identified C-terminal splice variant of Cav1.3 L-type Ca2+ channels. J Biol Chem 2011, 286:42736-42748.
9. Tan BZ, Jiang F, Tan MY, et al. Functional characterization of alternative splicing in the C terminus of L-type CaV1.3 channels. J Biol Chem 2011, 286:42725-42735.
10. Foell JD, Balijepalli RC, Delisle BP, et al. Molecular heterogeneity of calcium channel beta-subunits in canine and human heart: evidence for differential subcellular localization. Physiol Genomics 2004, 17:183-200.
11. Hofmann F, Biel M, Flockerzi V Molecular basis for Ca2+ channel diversity. Annu Rev Neurosci 1994, 17:399-418.
12. 2+ channels. Nature 2004, 429:675-680.
13. Van Petegem F, Clark KA, Chatelain FC, et al. Structure of a complex between a voltage-gated calcium channel beta-subunit and an alpha-subunit domain. Nature 2004, 429:671-675.
14. 2+ binding sites of the alpha 1-subunit. FEBS Lett 1994, 352:141-145.
15. Davies A, Hendrich J, Van Minh AT, et al. Functional biology of the alpha(2)delta subunits of voltage-gated calcium channels. Trends Pharmacol Sci 2007, 28:220-228.
16. Jay SD, Sharp AH, Kahl SD, et al. Structural characterization of the dihydropyridine-sensitive calcium channel alpha 2-subunit and the associated delta peptides. J Biol Chem 1991, 266:3287-3293.
17. Yang L, Katchman A, Morrow JP, et al. Cardiac L-type calcium channel (Cav1.2) associates with gamma subunits. FASEB J 2011, 25:928-936.
18. McCleskey EW, Almers W The Ca channel in skeletal muscle is a large pore. Proc Natl Acad Sci U S A 1985, 82:7149-7153.
19. 2+ channels. J Gen Physiol 1996, 108:363-374.
20. 2+ channels. J Biol Chem 1997, 272:30002-30008.
21. Guia A, Stern MD, Lakatta EG, et al. Ion concentration-dependence of rat cardiac unitary L-type calcium channel conductance. Biophys J 2001, 80:2742-2750.
22. Mangoni ME, Couette B, Marger L, et al. Voltage-dependent calcium channels and cardiac pacemaker activity: from ionic currents to genes. Prog Biophys Mol Biol 2006, 90:38-63.
23. 2+ channels in cardiac pacemaker activity. Proc Natl Acad Sci U S A 2003, 100:5543-5548.
24. Zhang Z, He Y, Tuteja D, et al. Functional roles of Cav1.3(alpha1D) calcium channels in atria: insights gained from gene-targeted null mutant mice. Circulation 2005, 112:1936-1944.
25. Seisenberger C, Specht V, Welling A, et al. Functional embryonic cardiomyocytes after disruption of the L-type alpha1C (Cav1.2) calcium channel gene in the mouse. J Biol Chem 2000, 275:39193-39199.
26. Mangoni ME, Nargeot J Genesis and regulation of the heart automaticity. Physiol Rev 2008, 88:919-982.
27. Zhang Z, Xu Y, Song H, et al. Functional roles of Ca(v)1.3 (alpha(1D)) calcium channel in sinoatrial nodes: insight gained using gene-targeted null mutant mice. Circ Res 2002, 90:981-987.
28. 2+ channels. Cell 2000, 102:89-97.
29. 2+ channel KO mouse. Am J Physiol Heart Circ Physiol 2008, 295:H2017-H2024.
30. Campbell DL, Giles WR, Hume JR, et al. Inactivation of calcium current in bull-frog atrial myocytes. J Physiol 1988, 403:287-315.
31. Kass RS, Sanguinetti MC Inactivation of calcium channel current in the calf cardiac Purkinje fiber: Evidence for voltage- and calcium-mediated mechanisms. J Gen Physiol 1984, 84:705-726.
32. Lee KS, Marban E, Tsien RW Inactivation of calcium channels in mammalian heart cells: Joint dependence on membrane potential and intracellular calcium. J Physiol 1985, 364:395-411.
33. Hadley RW, Hume JR An intrinsic potential-dependent inactivation mechanism associated with calcium channels in guinea-pig myocytes. J Physiol 1987, 389:205-222.
34. Richard S, Perrier E, Fauconnier J, et al. 'Ca(2+)-induced Ca(2+) entry' or how the L-type Ca(2+) channel remodels its own signalling pathway in cardiac cells. Prog Biophys Mol Biol 2006, 90:118-135.
35. 2+ -dependent inactivation of L-type calcium channels. Neuron 1999, 22:549-558.
36. 2+ channel depends on calmodulin. Proc Natl Acad Sci U S A 1999, 96:2435-2438.
37. Bers DM, Perez-Reyes E Ca channels in cardiac myocytes: Structure and function in Ca influx and intracellular Ca release. Cardiovasc Res 1999, 42:339-360.
38. 2+ current. Circ Res 1989, 64:977-990.
39. Hryshko LV, Bers DM Ca current facilitation during postrest recovery depends on Ca entry. Am J Physiol 1990, 259:H951-H961.
40. Zuhlke RD, Pitt GS, Deisseroth K, et al. Calmodulin supports both inactivation and facilitation of L-type calcium channels. Nature 1999, 399:159-162.
41. Scott JD, Santana LF A-kinase anchoring proteins: Getting to the heart of the matter. Circulation 2010, 121:1264-1271.
42. Beca S, Aschars-Sobbi R, Panama BK, et al. Regulation of murine cardiac function by phosphodiesterases type 3 and 4. Curr Opin Pharmacol 2011, 11:714-719.
43. 2+ channels work harder than others. J Gen Physiol 2010, 136:143-147.
44. Fuller MD, Emrick MA, Sadilek M, et al. Molecular mechanism of calcium channel regulation in the fight-or-flight response. Sci Signal 2010, 3:ra70.
45. Hulme JT, Lin TW, Westenbroek RE, et al. Beta-adrenergic regulation requires direct anchoring of PKA to cardiac CaV1.2 channels via a leucine zipper interaction with A kinase-anchoring protein 15. Proc Natl Acad Sci U S A 2003, 100:13093-13098.
46. Balijepalli RC, Foell JD, Hall DD, et al. Localization of cardiac L-type Ca(2+) channels to a caveolar macromolecular signaling complex is required for beta(2)-adrenergic regulation. Proc Natl Acad Sci U S A 2006, 103:7500-7505.
47. 2+ channels during hypertension and Timothy syndrome. Circ Res 2010, 106:748-756.
48. 2+ channels in cardiac pacemaking. J Pharmacol Sci 2005, 99:197-204.
49. 2+ channels in the heart. Cell Calcium 2006, 40:205-220.
50. Perez-Reyes E Molecular physiology of low-voltage-activated t-type calcium channels. Physiol Rev 2003, 83:117-161.
51. 2+ channel beta subunit depletion in nodosus ganglion neurons. J Neurosci 1997, 17:6621-6628.
52. Leuranguer V, Bourinet E, Lory P, et al. Antisense depletion of beta-subunits fails to affect T-type calcium channels properties in a neuroblastoma cell line. Neuropharmacology 1998, 37:701-708.
53. Dolphin AC, Wyatt CN, Richards J, et al. The effect of alpha2-delta and other accessory subunits on expression and properties of the calcium channel alpha1G. J Physiol 1999, 519(Pt 1):35-45.
54. Green PJ, Warre R, Hayes PD, et al. Kinetic modification of the alpha(1I) subunit-mediated T-type Ca(2+) channel by a human neuronal Ca(2+) channel gamma subunit. J Physiol 2001, 533:467-478.
55. Klugbauer N, Dai S, Specht V, et al. A family of gamma-like calcium channel subunits. FEBS Lett 2000, 470:189-197.
56. Gao B, Sekido Y, Maximov A, et al. Functional properties of a new voltage-dependent calcium channel alpha(2)delta auxiliary subunit gene (CACNA2D2). J Biol Chem 2000, 275:12237-12242.
57. Aromolaran KA, Benzow KA, Cribbs LL, et al. T-type current modulation by the actin-binding protein Kelch-like 1. Am J Physiol Cell Physiol 2010, 298:C1353-1362.
58. 2+ channels. J Biol Chem 2011, 286:2433-2444.
59. Lee JH, Gomora JC, Cribbs LL, et al. Nickel block of three cloned T-type calcium channels: Low concentrations selectively block alpha1H. Biophys J 1999, 77:3034-3042.
60. Chiang CS, Huang CH, Chieng H, et al. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice. Circ Res 2009, 104:522-530.
61. Iftinca MC, Zamponi GW Regulation of neuronal T-type calcium channels. Trends Pharmacol Sci 2009, 30:32-40.
62. Hagiwara N, Irisawa H, Kameyama M Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Physiol 1988, 395:233-253.
63. Perez-Reyes E Molecular characterization of T-type calcium channels. Cell Calcium 2006, 40:89-96.
64. Xie X, Van Deusen AL, Vitko I, et al. Validation of high throughput screening assays against three subtypes of Ca(v)3 T-type channels using molecular and pharmacologic approaches. Assay Drug Dev Technol 2007, 5:191-203.
65. Sawada T, Shinke T, Shite J, et al. Impact of cytochrome P450 2C19*2 polymorphism on intra-stent thrombus after drug-eluting stent implantation in Japanese patients receiving clopidogrel. Circ J 2011, 75:99-105.
66. 2+ channels and drug development. J Pharmacol Sci 2005, 99:214-220.
67. Chuang RS, Jaffe H, Cribbs L, et al. Inhibition of T-type voltage-gated calcium channels by a new scorpion toxin. Nat Neurosci 1998, 1:668-674.
68. Lacinova L T-type calcium channel blockers-new and notable. Gen Physiol Biophys 2011, 30:403-409.
69. Cribbs LL, Martin BL, Schroder EA, et al. Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart. Circ Res 2001, 88:403-407.
70. Cribbs L T-type calcium channel expression and function in the diseased heart. Channels (Austin) 2010, 4:447-452.
71. 2+ currents in canine Purkinje fibres. J Physiol 2007, 579:465-471.
72. Zhou C, Chen H, Lu F, et al. Cav3.1 (alpha1G) controls von Willebrand factor secretion in rat pulmonary microvascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 2007, 292:L833-L844.
73. Leuranguer V, Monteil A, Bourinet E, et al. T-type calcium currents in rat cardiomyocytes during postnatal development: contribution to hormone secretion. Am J Physiol Heart Circ Physiol 2000, 279:H2540-H2548.
74. 2+ channels from Cav3.2 to Cav3.1 during differentiation of embryonic stem cells to cardiac cell lineage. Circ J 2005, 69:1284-1289.
75. 2+ channel in murine hearts during the embryonic period. Am J Physiol Heart Circ Physiol 2004, 286:H2257-H2263.
76. Chandler NJ, Greener ID, Tellez JO, et al. Molecular architecture of the human sinus node: Insights into the function of the cardiac pacemaker. Circulation 2009, 119:1562-1575.
77. Han W, Bao W, Wang Z, et al. Comparison of ion-channel subunit expression in canine cardiac Purkinje fibers and ventricular muscle. Circ Res 2002, 91:790-797.
78. Ono K, Iijima T Cardiac T-type Ca(2+) channels in the heart. J Mol Cell Cardiol 2010, 48:65-70.
79. Mangoni ME, Traboulsie A, Leoni AL, et al. Bradycardia and slowing of the atrioventricular conduction in mice lacking CaV3.1/alpha1G T-type calcium channels. Circ Res 2006, 98:1422-1430.
80. Marger L, Mesirca P, Alig J, et al. Functional roles of Ca(v)1.3, Ca(v)3.1 and HCN channels in automaticity of mouse atrioventricular cells: Insights into the atrioventricular pacemaker mechanism. Channels (Austin) 2011, 5:251-261.
81. Le Quang K, Naud P, Qi XY, et al. Role of T-type calcium channel subunits in post-myocardial infarction remodelling probed with genetically engineered mice. Cardiovasc Res 2011, 91:420-428.
82. 2+ channel gene and current in post-infarction remodeled rat left ventricle. Cardiovasc Res 2000, 46:442-449.
83. 2+ current is expressed in hypertrophied adult feline left ventricular myocytes. Circ Res 1993, 73:777-782.
84. Schmitt R, Clozel JP, Iberg N, et al. Mibefradil prevents neointima formation after vascular injury in rats: Possible role of the blockade of the T-type voltage-operated calcium channel. Arterioscler Thromb Vasc Biol 1995, 15:1161-1165.
85. 2+ channels are abnormal in genetically determined cardiomyopathic hamster hearts. Circ Res 1994, 75:149-155.
86. Yanagi K, Takano M, Narazaki G, et al. Hyperpolarization-activated cyclic nucleotide-gated channels and T-type calcium channels confer automaticity of embryonic stem cell-derived cardiomyocytes. Stem Cells 2007, 25:2712-2719.
87. Wiese C, Grieskamp T, Airik R, et al. Formation of the sinus node head and differentiation of sinus node myocardium are independently regulated by Tbx18 and Tbx3. Circ Res 2009, 104:388-397.
88. Hoogaars WM, Engel A, Brons JF, et al. Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria. Genes Dev 2007, 21:1098-1112.
89. Nilius B, Talavera K, Verkhratsky A T-type calcium channels: The never ending story. Cell Calcium 2006, 40:81-88.
90. Madle A, Linhartova K, Koza J Effects of the T-type calcium channel blockade with oral mibefradil on the electrophysiologic properties of the human heart. Med Sci Monit 2001, 7:74-77.
91. 2+ channels. Science 2003, 302:1416-1418.
92. 2+ release contributes to automaticity in cat atrial pacemaker cells. J Physiol 2000, 524(Pt 2):415-422.
93. 2+ release from sarcoplasmic reticulum in the regulation of sinoatrial node automaticity. Heart Vessels 1996, 11:234-241.
94. 2+ clocks and surface membrane voltage clocks controls the timekeeping mechanism of the heart's pacemaker. Circ Res 2010, 106:659-673.
95. 2+ channels have different effects on myocyte contractility and induce unique cardiac phenotypes. Circ Res 2008, 103:1109-1119.
96. 2+ channels and pharmacological blockade: Potential pathophysiological relevance. Cardiovasc Drugs Ther 1997, 111:723-739.
97. 2+ channels are involved in high glucose-induced rat neonatal cardiomyocyte proliferation. Pediatr Res 2005, 57:550-556.
98. Sandmann S, Min JY, Meissner A, et al. Effects of the calcium channel antagonist mibefradil on haemodynamic parameters and myocardial Ca(2+)-handling in infarct-induced heart failure in rats. Cardiovasc Res 1999, 44:67-80.
99. Parent de Curzon O, Ghaleh B, Hittinger L, et al. Beneficial effects of the T- and L-type calcium channel antagonist, mibefradil, against exercise-induced myocardial stunning in dogs. J Cardiovasc Pharmacol 2000, 35:240-248.
100. Fareh S, Benardeau A, Nattel S Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs. Cardiovasc Res 2001, 49:762-770.
101. Fareh S, Benardeau A, Thibault B, et al. The T-type Ca(2+) channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs. Circulation 1999, 100:2191-2197.
102. 2+ channel blockade prevents sudden death in mice with heart failure. Circulation 2009, 120:743-752.
103. Chen YC, Chen SA, Chen YJ, et al. T-type calcium current in electrical activity of cardiomyocytes isolated from rabbit pulmonary vein. J Cardiovasc Electrophysiol 2004, 15:567-571.
104. Ohashi N, Mitamura H, Tanimoto K, et al. A comparison between calcium channel blocking drugs with different potencies for T- and L-type channels in preventing atrial electrical remodeling. J Cardiovasc Pharmacol 2004, 44:386-392.
105. Xia QG, Reinecke A, Dorenkamp M, et al. Comparison of cardioprotective effects of mibefradil and ramipril in stroke-prone spontaneously hypertensive rats. Acta Pharmacol Sin 2004, 25:763-768.
106. Takebayashi S, Li Y, Kaku T, et al. Remodeling excitation-contraction coupling of hypertrophied ventricular myocytes is dependent on T-type calcium channels expression. Biochem Biophys Res Commun 2006, 345:766-773.
107. Po AL, Zhang WY What lessons can be learnt from withdrawal of mibefradil from the market?. Lancet 1998, 351:1829-1830.
108. 2+ current antagonizes cardiac hypertrophy through a NOS3-dependent mechanism in mice. J Clin Invest 2009, 119:3787-3796.
109. Minke B Drosophila mutant with a transducer defect. Biophys Struct Mech 1977, 3:59-64.
110. Ramsey IS, Delling M, Clapham DE An introduction to TRP channels. Ann Rev Physiol 2006, 68:619-647.
111. Vennekens R Emerging concepts for the role of TRP channels in the cardiovascular system. J Physiol 2011, 589:1527-1534.
112. Rose RA, Hatano N, Ohya S, et al. C-type natriuretic peptide activates a non-selective cation current in acutely isolated rat cardiac fibroblasts via natriuretic peptide C receptor-mediated signalling. J Physiol 2007, 580:255-274.
113. Watanabe H, Murakami M, Ohba T, et al. TRP channel and cardiovascular disease. Pharmacol Ther 2008, 118:337-351.
114. Eder P, Molkentin JD TRPC channels as effectors of cardiac hypertrophy. Circ Res 2011, 108:265-272.
115. Harada M, Luo X, Qi XY, et al. Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation. Circulation 2012, 126:2051-2064.
116. 2+ signals confer fibrogenesis in human atrial fibrillation. Circ Res 2010, 106:992-1003.
117. Gwanyanya A, Amuzescu B, Zakharov SI, et al. Magnesium-inhibited, TRPM6/7-like channel in cardiac myocytes: Permeation of divalent cations and pH-mediated regulation. J Physiol 2004, 559:761-776.
118. Gwanyanya A, Sipido KR, Vereecke J, et al. ATP and PIP2 dependence of the magnesium-inhibited, TRPM7-like cation channel in cardiac myocytes. Am J Physiol Cell Physiol 2006, 291:C627-C635.
119. 2+ influx and expression of TRPC genes in mouse sinoatrial node. Circ Res 2007, 100:1605-1614.
120. Clapham DE TRP channels as cellular sensors. Nature 2003, 426:517-524.
121. Clapham DE, Runnels LW, Strubing C The TRP ion channel family. Nat Rev Neurosci 2001, 2:387-396.
122. Nilius B, Talavera K, Owsianik G, et al. Gating of TRP channels: A voltage connection?. J Physiol 2005, 567:35-44.
123. Heineke J, Molkentin JD Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006, 7:589-600.
124. 2+ currents in compensated hypertrophy and heart failure. Cardiovasc Res 1998, 37:300-311.
125. 2+ influx protects cardiac morphology and ventricular function in K(v)4.2N transgenic mice. Circulation 2002, 105:1850-1856.
126. Bush EW, Hood DB, Papst PJ, et al. Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling. J Biol Chem 2006, 281:33487-33496.
127. Seth M, Zhang ZS, Mao L, et al. TRPC1 channels are critical for hypertrophic signaling in the heart. Circ Res 2009, 105:1023-1030.
128. Niizeki T, Takeishi Y, Kitahara T, et al. Diacyl-glycerol kinase-epsilon restores cardiac dysfunction under chronic pressure overload: A new specific regulator of Galpha(q) signaling cascade. Am J Physiol Heart Circ Physiol 2008, 295:H245-H255.
129. Ohba T, Watanabe H, Murakami M, et al. Upregulation of TRPC1 in the development of cardiac hypertrophy. J Mol Cell Cardiol 2007, 42:498-507.
130. Brenner JS, Dolmetsch RE TrpC3 regulates hypertrophy-associated gene expression without affecting myocyte beating or cell size. PLoS One 2007, 2:e802.
131. Kiyonaka S, Kato K, Nishida M, et al. Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound. Proc Natl Acad Sci U S A 2009, 106:5400-5405.
132. Wu X, Eder P, Chang B, et al. TRPC channels are necessary mediators of pathologic cardiac hypertrophy. Proc Natl Acad Sci U S A 2010, 107:7000-7005.
133. Baudino TA, Carver W, Giles W, et al. Cardiac fibroblasts: Friend or foe?. Am J Physiol Heart Circ Physiol 2006, 291:H1015-H1026.
134. Souders CA, Bowers SL, Baudino TA Cardiac fibroblast: The renaissance cell. Circ Res 2009, 105:1164-1176.
135. Yue L, Xie J, Nattel S Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc Res 2011, 89:744-753.
136. 2+ entry through TRP-C channels regulates fibroblast biology in chronic atrial fibrillation. Circulation 2012, 126:2039-2041.